APA (7th ed.) Citation

Sylvie, C., Lila, B., Claire, D., Charles, B., Jean-François, T., group, t. C. R., . . . Maurer, Y. (2023). Which severe COVID-19 patients could benefit from high dose dexamethasone? A Bayesian post-hoc reanalysis of the COVIDICUS randomized clinical trial. Annals of Intensive Care, 13(1), 1. https://doi.org/10.1186/s13613-023-01168-z

Chicago Style (17th ed.) Citation

Sylvie, Chevret, et al. "Which Severe COVID-19 Patients Could Benefit from High Dose Dexamethasone? A Bayesian Post-hoc Reanalysis of the COVIDICUS Randomized Clinical Trial." Annals of Intensive Care 13, no. 1 (2023): 1. https://doi.org/10.1186/s13613-023-01168-z.

MLA (9th ed.) Citation

Sylvie, Chevret, et al. "Which Severe COVID-19 Patients Could Benefit from High Dose Dexamethasone? A Bayesian Post-hoc Reanalysis of the COVIDICUS Randomized Clinical Trial." Annals of Intensive Care, vol. 13, no. 1, 2023, p. 1, https://doi.org/10.1186/s13613-023-01168-z.